Allergic conjunctivitis is a common ocular condition characterized by inflammation of the conjunctiva due to an allergic reaction. Symptoms include itching, redness, watering, and swelling of the eyes. Vernal catarrhal conjunctivitis is a more severe form, often seen in warmer months. Managing these conditions often involves reducing the inflammatory response triggered by allergens. NINGBO INNO PHARMCHEM CO.,LTD. supplies high-quality Pemirolast Potassium, a vital ingredient for ophthalmic formulations targeting these eye conditions.

Pemirolast Potassium, available as pharmaceutical grade 99% powder with CAS 100299-08-9, is an effective mast cell stabilizer. In ophthalmic applications, it works by preventing mast cells in the conjunctiva from releasing histamine and other inflammatory mediators that cause the symptoms of allergic conjunctivitis. When formulated into eye drops, Pemirolast Potassium provides targeted relief, reducing itching and inflammation. This makes it an excellent choice for developing both over-the-counter and prescription treatments for allergic eye conditions, including the more severe vernal catarrhal conjunctivitis.

The demand for safe and effective ophthalmic treatments for allergic conjunctivitis is significant. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our Pemirolast Potassium meets the highest pharmaceutical standards required for ocular products. Our commitment to quality means that formulators can rely on our product for consistent performance and patient safety. If you are a pharmaceutical manufacturer looking to buy Pemirolast Potassium for your ophthalmic product line, NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner. We understand the critical nature of ophthalmic ingredients and are dedicated to supporting your development process. Contact us to learn more about our Pemirolast Potassium and how it can be incorporated into your solutions for allergic conjunctivitis and related ocular conditions.